194 related articles for article (PubMed ID: 10375541)
21. Influence of the charge state on the structures and interactions of vancomycin antibiotics with cell-wall analogue peptides: experimental and theoretical studies.
Yang Z; Vorpagel ER; Laskin J
Chemistry; 2009; 15(9):2081-90. PubMed ID: 19156658
[TBL] [Abstract][Full Text] [Related]
22. Conformational studies of resin-bound vancomycin and the complex of vancomycin and Ac2-L-Lys-D-Ala-D-Ala.
Yao NH; He WY; Lam KS; Liu G
J Comb Chem; 2005; 7(1):123-9. PubMed ID: 15638491
[TBL] [Abstract][Full Text] [Related]
23. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
Wu ZC; Boger DL
Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
[TBL] [Abstract][Full Text] [Related]
24. Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium.
Cooper MA; Williams DH
Chem Biol; 1999 Dec; 6(12):891-9. PubMed ID: 10631517
[TBL] [Abstract][Full Text] [Related]
25. Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin.
Chiosis G; Boneca IG
Science; 2001 Aug; 293(5534):1484-7. PubMed ID: 11520986
[TBL] [Abstract][Full Text] [Related]
26. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
[TBL] [Abstract][Full Text] [Related]
27. Cooperativity between non-polar and ionic forces in the binding of bacterial cell wall analogues by vancomycin in aqueous solution.
Cristofaro MF; Beauregard DA; Yan H; Osborn NJ; Williams DH
J Antibiot (Tokyo); 1995 Aug; 48(8):805-10. PubMed ID: 7592024
[TBL] [Abstract][Full Text] [Related]
28. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
[TBL] [Abstract][Full Text] [Related]
29. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
[TBL] [Abstract][Full Text] [Related]
30. Quantitative measurements of vancomycin binding to self-assembled peptide monolayers on chips by quartz crystal microbalance.
Tseng MC; Chang YP; Chu YH
Anal Biochem; 2007 Dec; 371(1):1-9. PubMed ID: 17919449
[TBL] [Abstract][Full Text] [Related]
31. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues.
Allen NE; LeTourneau DL; Hobbs JN
Antimicrob Agents Chemother; 1997 Jan; 41(1):66-71. PubMed ID: 8980756
[TBL] [Abstract][Full Text] [Related]
32. Structures of glycopeptide antibiotics with peptides that model bacterial cell-wall precursors.
Lehmann C; Bunkóczi G; Vértesy L; Sheldrick GM
J Mol Biol; 2002 May; 318(3):723-32. PubMed ID: 12054818
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanism of VanHst, an alpha-ketoacid dehydrogenase required for glycopeptide antibiotic resistance from a glycopeptide producing organism.
Marshall CG; Zolli M; Wright GD
Biochemistry; 1999 Jun; 38(26):8485-91. PubMed ID: 10387095
[TBL] [Abstract][Full Text] [Related]
34. Design and evaluation of analogues of the bacterial cell-wall peptidoglycan motif L-Lys-D-Ala-D-Ala for use in a vancomycin biosensor.
Hernout O; Berthoin K; Delattre I; Tulkens PM; Carryn S; Marchand-Brynaert J
Bioorg Med Chem Lett; 2007 Nov; 17(21):5758-62. PubMed ID: 17855088
[TBL] [Abstract][Full Text] [Related]
35. Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
Fesik SW; Armitage IM; Ellestad GA; McGahren WJ
Mol Pharmacol; 1984 Mar; 25(2):281-6. PubMed ID: 6700574
[TBL] [Abstract][Full Text] [Related]
36. Peripheral modifications of [Ψ[CH
Okano A; Isley NA; Boger DL
Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5052-E5061. PubMed ID: 28559345
[TBL] [Abstract][Full Text] [Related]
37. D-Alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin-resistant Leuconostoc mesenteroides. Effects of a phenylalanine 261 to tyrosine mutation.
Park IS; Walsh CT
J Biol Chem; 1997 Apr; 272(14):9210-4. PubMed ID: 9083053
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of a D-Ala-D-Ala peptide isostere via olefin cross-metathesis and evaluation of vancomycin binding.
Quinn RK; Cianci AL; Beaudoin JA; Sculimbrene BR
Bioorg Med Chem Lett; 2010 Aug; 20(15):4382-5. PubMed ID: 20594838
[TBL] [Abstract][Full Text] [Related]
39. Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding.
Goldman RC; Baizman ER; Longley CB; Branstrom AA
FEMS Microbiol Lett; 2000 Feb; 183(2):209-14. PubMed ID: 10675585
[TBL] [Abstract][Full Text] [Related]
40. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy.
Treviño J; Bayón C; Ardá A; Marinelli F; Gandolfi R; Molinari F; Jimenez-Barbero J; Hernáiz MJ
Chemistry; 2014 Jun; 20(24):7363-72. PubMed ID: 24805824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
